Melchizedek Penacerrada

3.2k citations
12 papers · 2.2k · 6 hit papers · h-index 9

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
  • Genetics top 5%
    • Genetic Associations and Epidemiology

Papers in

    • COVID-19 Clinical Research Studies 5
    • SARS-CoV-2 and COVID-19 Research 2
    • Genetic Associations and Epidemiology 7

Melchizedek Penacerrada

11 papers receiving 2.1k citations

Melchizedek Penacerrada's Hit Papers

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 2023 · 125 citations
1250+2+4Years since publication200400600

Peers

Melchizedek Penacerrada
Comparison fields: 5 of 96
  • Infectious Diseases 1.3k
  • Genetics 521
  • Applied Microbiology and Biotechnology 34
  • Internal Medicine 28
  • Immunology 111
Replace Mark Vertue with:
Mark Vertue United Kingdom
Carl Murphy United Kingdom
Alison Lewis United Kingdom
Annette Nilsson United Kingdom
Joanne Bradley-Potts United Kingdom
Mark Birt United Kingdom
Zohra Omar United Kingdom
Susan Hope United Kingdom
Olugbenga Akinkugbe United Kingdom
Jonathan Hatton United Kingdom
Melchizedek Penacerrada relative to Mark Vertue United Kingdom Mark Vertue's profile →
Citations per field
00.5×1.6×
Mark Vertue · 1×
Citations per year

Countries citing papers authored by Melchizedek Penacerrada

Since Specialization
Citations

This map shows the geographic impact of Melchizedek Penacerrada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melchizedek Penacerrada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melchizedek Penacerrada more than expected).

Fields of papers citing papers by Melchizedek Penacerrada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melchizedek Penacerrada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melchizedek Penacerrada. The network helps show where Melchizedek Penacerrada may publish in the future.

No co-authors to show.

All Works

12 of 12 papers shown
#Work
1
Mapping the human genetic architecture of COVID-19
Hit paper breakdown →
2021656
2
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021411
3
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
4
Whole-genome sequencing reveals host factors underlying critical COVID-19
Hit paper breakdown →
2022233
5 2021213
6
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
Hit paper breakdown →
2020181
7
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Hit paper breakdown →
2023125
8 202360
9 202126
10 20248
11 20245
12 20210

About Melchizedek Penacerrada

Melchizedek Penacerrada is a scholar working on Infectious Diseases, Genetics, Hepatology, Surgery and Nuclear Energy and Engineering, having authored 12 papers that have together received 2.2k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (7 papers), COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Esophageal Cancer Research and Treatment (1 paper) and Liver Disease and Transplantation (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Genetics (521 citations), Applied Microbiology and Biotechnology (34 citations), Internal Medicine (28 citations) and Immunology (111 citations). Melchizedek Penacerrada has collaborated with scholars based in United Kingdom, Sweden and Vietnam. Their work appears in journals such as The Lancet, Nature, Human Genetics, Trials and Human Genetics and Genomics Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact